Erste Asset Management’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,700
| Closed | -$81.5K | – | 729 |
|
|
2024
Q3 | $81.5K | Hold |
2,700
| – | – | ﹤0.01% | 504 |
|
|
2024
Q2 | $74.5K | Hold |
2,700
| – | – | ﹤0.01% | 500 |
|
|
2024
Q1 | $110K | Hold |
2,700
| – | – | ﹤0.01% | 487 |
|
|
2023
Q4 | $114K | Hold |
2,700
| – | – | ﹤0.01% | 500 |
|
|
2023
Q3 | $84.8K | Hold |
2,700
| – | – | ﹤0.01% | 504 |
|
|
2023
Q2 | $169K | Hold |
2,700
| – | – | ﹤0.01% | 498 |
|
|
2023
Q1 | $116K | Hold |
2,700
| – | – | ﹤0.01% | 526 |
|
|
2022
Q4 | $178K | Hold |
2,700
| – | – | ﹤0.01% | 499 |
|
|
2022
Q3 | $400K | Hold |
2,700
| – | – | 0.01% | 441 |
|
|
2022
Q2 | $362K | Hold |
2,700
| – | – | 0.01% | 460 |
|
|
2022
Q1 | $289K | Buy |
+2,700
| New | +$289K | 0.01% | 485 |
|